Vaitkevicius VK - Search Results

1

Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.

Mohammad RM, Li Y, Mohamed AN, Pettit GR, Adsay V, Vaitkevicius VK, Al-Katib AM, Sarkar FH. Mohammad RM, et al. Among authors: vaitkevicius vk. Pancreas. 1999 Nov;19(4):353-61. doi: 10.1097/00006676-199911000-00006. Pancreas. 1999. PMID: 10547195

2

Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.

Pernick NL, Sarkar FH, Philip PA, Arlauskas P, Shields AF, Vaitkevicius VK, Dugan MC, Adsay NV. Pernick NL, et al. Among authors: vaitkevicius vk. Pancreas. 2003 Jan;26(1):28-32. doi: 10.1097/00006676-200301000-00006. Pancreas. 2003. PMID: 12499914

3

Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.

Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH. Mohammad RM, et al. Among authors: vaitkevicius vk. Pancreas. 1998 Jan;16(1):19-25. doi: 10.1097/00006676-199801000-00004. Pancreas. 1998. PMID: 9436858

4

Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.

Joshi US, Dergham ST, Chen YQ, Dugan MC, Crissman JD, Vaitkevicius VK, Sarkar FH. Joshi US, et al. Among authors: vaitkevicius vk. Pancreas. 1998 Mar;16(2):107-13. doi: 10.1097/00006676-199803000-00001. Pancreas. 1998. PMID: 9510131

5

An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.

Mohammad RM, Al-Katib A, Pettit GR, Vaitkevicius VK, Joshi U, Adsay V, Majumdar AP, Sarkar FH. Mohammad RM, et al. Among authors: vaitkevicius vk. Clin Cancer Res. 1998 Apr;4(4):887-94. Clin Cancer Res. 1998. PMID: 9563882

6

Molecular analysis of the p53 gene in pancreatic adenocarcinoma.

Li Y, Bhuiyan M, Vaitkevicius VK, Sarkar FH. Li Y, et al. Among authors: vaitkevicius vk. Diagn Mol Pathol. 1998 Feb;7(1):4-9. doi: 10.1097/00019606-199802000-00002. Diagn Mol Pathol. 1998. PMID: 9646028

7

Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma.

Li Y, Bhuiyan M, Vaitkevicius VK, Sarkar FH. Li Y, et al. Among authors: vaitkevicius vk. Pancreas. 1999 Jan;18(1):104-10. doi: 10.1097/00006676-199901000-00013. Pancreas. 1999. PMID: 9888666

8

Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.

Adsay NV, Dergham ST, Koppitch FC, Dugan MC, Mohamed AN, Vaitkevicius VK, Sarkar FH. Adsay NV, et al. Among authors: vaitkevicius vk. Pancreas. 1999 Mar;18(2):111-6. doi: 10.1097/00006676-199903000-00001. Pancreas. 1999. PMID: 10090407

9

Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer.

He Z, Evelhoch JL, Mohammad RM, Adsay NV, Pettit GR, Vaitkevicius VK, Sarkar FH. He Z, et al. Among authors: vaitkevicius vk. Pancreas. 2000 Jul;21(1):69-76. doi: 10.1097/00006676-200007000-00054. Pancreas. 2000. PMID: 10881935

10

CD95-related apoptotic machinery is functional in pancreatic cancer cells.

Glazyrin AL, Adsay VN, Vaitkevicius VK, Sarkar FH. Glazyrin AL, et al. Among authors: vaitkevicius vk. Pancreas. 2001 May;22(4):357-65. doi: 10.1097/00006676-200105000-00004. Pancreas. 2001. PMID: 11345135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters